Use of Vaping as a Smoking Cessation Aid: A Review of Clinical Trials.

e-cigarettes nicotine smoking aid smoking cessation vaping

Journal

Journal of multidisciplinary healthcare
ISSN: 1178-2390
Titre abrégé: J Multidiscip Healthc
Pays: New Zealand
ID NLM: 101512691

Informations de publication

Date de publication:
2023
Historique:
received: 04 05 2023
accepted: 21 07 2023
medline: 2 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

Smoking is a global public health concern, with a significant negative impact on human health and healthcare spending. Vaping, or the use of electronic cigarettes (e-cigarettes), has emerged as a popular alternative to traditional nicotine replacement therapies (NRTs) for smoking cessation. While considered less harmful than combustible cigarettes, the long-term health effects of e-cigarettes (vaping) are unknown. Therefore, this study aimed to identify and provide a comprehensive overview of the performance of vaping in clinical trials. A search was conducted in the ClinicalTrials.gov database on April 14th, 2023, using the search term "smoking cessation, e-cigarettes, NRTs, and vaping". Inclusion and exclusion criteria were defined to identify relevant clinical trials. Randomized controlled trials (RCTs) and non-randomized clinical trials that evaluated vaping as a therapeutic approach to smoking cessation were included. A total of 87 clinical trials were identified, of which only seven were related to smoking cessation through vaping as a form of treatment. The primary endpoint was the effect of vaping as smoking cessation, and the secondary endpoints were patients' abstinence rate, withdrawal symptoms, and adverse events of e-cigarettes. Most of the trials used e-cigarettes as an intervention, with some trials including a combination of e-cigarettes and other NRTs. The trials lasted from 4 weeks to 12 months. The overall results of the trials indicated that vaping was effective in helping smokers to quit. It was also associated with a lower risk of adverse events than combustible cigarettes. Vaping appears to be an effective method for smoking cessation, and it is associated with a lower risk of adverse events than combustible cigarettes.

Identifiants

pubmed: 37529148
doi: 10.2147/JMDH.S419945
pii: 419945
pmc: PMC10389080
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

2137-2144

Informations de copyright

© 2023 Ashour.

Déclaration de conflit d'intérêts

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Toxicol In Vitro. 2021 Sep;75:105204
pubmed: 34186184
Nicotine Tob Res. 2019 Apr 17;21(5):695-698
pubmed: 29660054
Contemp Clin Trials Commun. 2020 Nov 07;20:100657
pubmed: 33294725
J Risk Uncertain. 2020 Jun;60(3):207-228
pubmed: 32943812
Tob Control. 2008 Apr;17(2):132-41
pubmed: 18375736
Am J Public Health. 2021 Feb;111(2):224-226
pubmed: 33439715
Bull World Health Organ. 1992;70(2):269-75
pubmed: 1600587
Curr Cardiol Rep. 2020 Oct 9;22(12):155
pubmed: 33037523
BMJ. 1994 Oct 8;309(6959):901-11
pubmed: 7755693
Lancet. 2017 May 13;389(10082):1885-1906
pubmed: 28390697
Lancet. 2013 Jan 12;381(9861):133-41
pubmed: 23107252
MMWR Morb Mortal Wkly Rep. 2000 Jul 28;49(29):665-8
pubmed: 10943254
Health Policy. 2015 Jan;119(1):50-6
pubmed: 25497715
Annu Rev Med. 2016;67:467-86
pubmed: 26332005
JAMA Intern Med. 2014 Dec;174(12):1922-8
pubmed: 25317719
Tob Control. 2012 Mar;21(2):172-80
pubmed: 22345242
BMJ. 2017 Jul 26;358:j3262
pubmed: 28747333
Curr Environ Health Rep. 2015 Dec;2(4):423-9
pubmed: 26452675
Toxicol Rep. 2022 Jun 16;9:1357-1368
pubmed: 36561957
Addict Sci Clin Pract. 2013 Mar 05;8:5
pubmed: 23497603
Addiction. 2023 Feb;118(2):340-352
pubmed: 36110040
Chest. 2006 May;129(5):1288-97
pubmed: 16685021
Addiction. 2018 Nov;113(11):2099-2106
pubmed: 29920842
Am Rev Respir Dis. 1988 Apr;137(4):918-23
pubmed: 3355000
Toxicology. 2016 Jul 15;365:67-75
pubmed: 27477296
Health Technol Assess. 2019 Aug;23(43):1-82
pubmed: 31434605
Environ Health Perspect. 2003 Apr;111(4):513-7
pubmed: 12676608
Nicotine Tob Res. 2021 Mar 19;23(4):635-642
pubmed: 32803250
Am J Prev Med. 2017 Mar;52(3):339-346
pubmed: 27890516
Int J Public Health. 2016 Mar;61(2):215-24
pubmed: 26650455
Chem Res Toxicol. 2001 Jul;14(7):767-90
pubmed: 11453723
Addict Behav. 2021 Feb;113:106687
pubmed: 33045643
Toxicol Rep. 2021 Jan 27;8:282-294
pubmed: 33552927
Rev Invest Clin. 2019;71(1):7-16
pubmed: 30810545
Am Rev Respir Dis. 1973 Jul;108(1):40-8
pubmed: 4715969
J Community Health. 2016 Dec;41(6):1130-1139
pubmed: 27393143
Elife. 2020 Mar 24;9:
pubmed: 32207405
Int J Environ Res Public Health. 2021 Feb 27;18(5):
pubmed: 33673413
Tob Control. 2023 Aug;32(e2):e145-e152
pubmed: 35131948
Tob Control. 2019 Nov;28(6):629-635
pubmed: 30459182
Tob Control. 2021 Nov;30(6):630-637
pubmed: 32893187
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Addict Behav. 2023 Jan;136:107483
pubmed: 36084416
Addiction. 2021 Oct;116(10):2825-2836
pubmed: 33751671
Am J Prev Med. 2010 Feb;38(2 Suppl):S275-89
pubmed: 20117612
Metallomics. 2011 Nov;3(11):1181-98
pubmed: 21799956
Int J Gen Med. 2011 Feb 01;4:115-20
pubmed: 21475626
Curr Opin Pharmacol. 2012 Jun;12(3):229-37
pubmed: 22398322
Addiction. 2014 Sep;109(9):1531-40
pubmed: 24846453

Auteurs

Ahmed M Ashour (AM)

Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.

Classifications MeSH